Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
about
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityCD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.Inflammation, immune activation, and cardiovascular disease in HIV.The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.Type I interferon: understanding its role in HIV pathogenesis and therapy.Ageing with HIV: a multidisciplinary review.Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS.The enigma of the clandestine association between chloroquine and HIV-1 infection.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionStrategies to limit immune-activation in HIV patients.Immune Suppression by Myeloid Cells in HIV Infection: New Targets for ImmunotherapyImmunosenescence and hurdles in the clinical management of older HIV-patients.Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesExpansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection.
P2860
Q26773267-BAA650CF-C22B-4423-8F17-96C71CD2E6ECQ35801549-B33E3483-7561-46E1-A867-A4227916404BQ36957752-26FED374-9CAE-4DB1-A311-3F17792E36EDQ37062264-8F2E6295-6FD3-4309-B515-F453573D576DQ38348388-929B65E6-5B41-4419-9909-E43A72CFC39FQ38490362-87FB5AE1-87B0-4761-AE99-F1EEDD4BDA7FQ38530430-E5EB4A53-8605-4AB1-8669-A990A38949EEQ38559764-03D1403E-5565-4D8D-B248-D9E7E8EEAE01Q38749963-AF35B96F-3239-41F5-B0E0-9E92CC40264EQ38985926-96FF7A34-86C6-4ABC-AD1F-55D9B224AB02Q39048479-092224C8-C544-4245-8B28-D05877FE9B16Q39170367-F26E2EBE-3025-464F-8024-37539C52DD71Q39335635-6705F293-7A25-4196-BBD9-1640141BE5F1Q39360987-2B1FF34D-5003-47DA-8473-E5EBC545389FQ40761860-E359752C-F1ED-429C-9CA8-641434FECFC6Q45324456-0BE5CDE5-213D-49D0-8857-9266B549FFD4
P2860
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Assessment of chloroquine as a ...... eiving antiretroviral therapy.
@en
type
label
Assessment of chloroquine as a ...... eiving antiretroviral therapy.
@en
prefLabel
Assessment of chloroquine as a ...... eiving antiretroviral therapy.
@en
P2093
P2860
P356
P1433
P1476
Assessment of chloroquine as a ...... eiving antiretroviral therapy.
@en
P2093
C Kanagaratham
M-A Jenabian
P2860
P356
10.1111/HIV.12171
P577
2014-06-02T00:00:00Z